Laparoscopic Heller myotomy is equally efficient and safe in patients who had pre-myotomy endoscopic interventions when compared with those with no intervention.
Journal Title: Current Thoracic Surgery - Year 2017, Vol 2, Issue 1
Abstract
Background: Endoscopic treatment (ET) methods for achalasia such as balloon dilatation and botulinum toxin injection has good success for short and medium term management of achalasia. However some patients either need repeat attempts or referred to surgery. In this study we analyzed and compared the perioperative and disease specific quality of life outcomes of achalasia patients who either underwent surgery as a first line treatment and the ones who underwent ET method prior to surgery. Materials and Methods: The patients who underwent standard of care diagnostic workup and surgery for achalasia by the same surgical team between 2007 and 2014 were recorded in a prospective database. The patients who underwent surgery as a first line treatment (Group 1, n = 55) and the patients who underwent prior ET (Group 2, n = 33) were identified. Demographic data, peroperative complications, length of hospital stay, pre- and postoperative Eckardt scores were recorded and analyzed. Results: A total of 88 patients out of 105 were available for follow up with average follow up time of 61.9 ± 35.8 months. The mean age was 43.3 ± 15.6. Mean hospital stay was 2.3 ± 0.8 days and there was no mortality. Average duration of the effectivity of ET before myotomy was 5.7 ± 7.7 months. Peroperative complications not significantly accumulated in either group. Both groups showed comparable drop in Eckardt scores. Conclusions: Heller myotomy and Dor fundoplication is a safe and durable option for treatment of achalasia for both treatment naive patients and patients with previous repeated ET modalities.
Authors and Affiliations
Zeynep Bilgi, Adamu Issaka, Hasan Fevzi Batırel
Keywords
Related Articles
- EP ID EP292643
- DOI 10.26663/cts.2017.0001
- Views 113
- Downloads 0
Upregulated mRNA expression of mTOR in surgically resected early stage non-small cell lung carcinoma: a potential molecular targeted therapy
Background: Non-small cell lung cancer (NSCLC) comprises about 85% of all lung cancers. Although many attempts for early detection and treatment, prognosis of NSCLC is still poor. In recent years the pathways and the ge...
Current treatment options for post-thoracotomy pain syndrome: a review
Thoracotomy is one of the most painful surgical procedures known. Chronic pain in the postoperative period after thoracotomy is a common complication. Post-thoracotomy pain syndrome (PTPS) is a chronic pain with neuropat...
Application of tracheal stomal stent for upper airway obstructions: report of four cases
Upper airway obstructions with malignant or benign causes have high mortality and morbidity rates and may lead to sudden respiratory distress. Head-neck tumors, cervical esophagus tumors, longterm intubation, and tracheo...
Inflammatory myofibroblastic tumor: a case of a rare tumor of lung
Inflammatory myofibroblastic tumor (IMT) is a rare thoracic lesion, the diagnosis of which should be supported by histological and immunochemical examinations. Although this is known as a benign tumor, it should be compl...
Role of surgical fixation in rib fractures: an experimental study
Background: Rib fractures occur usually after thoracic traumas. Multiple and displaced fractures are occasionally associated with respiratory complications. That is why treatment for rib fractures should be done properly...